Previous 10 | Next 10 |
home / stock / cqpty / cqpty news
REHOVOT, Israel , May 5, 2020 /PRNewswire/ -- CollPlant (NASDAQ:CLGN) , a regenerative and aesthetics medicine company, today announced that it will be hosting a webinar on Tuesday, May 12, 2020 at 11 am EDT / 6 pm IDT that will feature its Co-Founder and Chief Scientist, Professor ...
REHOVOT, Israel , April 1, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced financial results for the full year ended December 31, 2019 and provided an update on the Company's business developments. Certain metrics, includi...
REHOVOT, Israel , Feb. 14, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative and aesthetic medicine company, announced it has entered into definitive agreements for up to $4.45 million . The capital raise is by way of a non-brokered private...
REHOVOT, Israel , Feb. 10, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced the appointment of Roger J. Pomerantz , M.D., F.A.C.P. to its Board of Directors as Chairman, effective immediately. Dr. Pomerantz is cur...
REHOVOT, Israel , Feb. 4, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced the launch of its updated corporate website. The new website has a clean uncluttered design, improved functionality and enhanced rich content fo...
ROCK HILL, South Carolina and REHOVOT, Israel , Jan. 13, 2020 /PRNewswire/ -- Today, 3D Systems (NYSE: DDD) and CollPlant Biotechnologies (NASDAQ: CLGN) , announced signing a joint development agreement intended to play a pivotal role in advancing and accelerating breakthroug...
REHOVOT, Israel , Jan. 6, 2020 /PRNewswire/ -- CollPlant (NASDAQ:CLGN), a regenerative medicine company, today announced it is now part of a new public-private ManufacturingUSA initiative, the Advanced Regenerative Manufacturing Institute (ARMI). Headquartered in Manchester, New Hampsh...
REHOVOT, Israel , Dec. 19, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that Yehiel Tal , Chief Executive Officer of CollPlant Biotechnologies, has issued a Letter to Shareholders, the full text of which follows below. ...
REHOVOT, Israel , Nov. 29, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced financial results for the third quarter ended September 30, 2019 and provided an update on the Company's business developments. Certain metrics, including ...
REHOVOT, Israel , Oct. 22, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the Company's Chief Executive Officer Yehiel Tal was recently appointed as a member of the Industry Relations Committee of ISBF (International Society for Bi...
News, Short Squeeze, Breakout and More Instantly...
Collplant Holdings Company Name:
CQPTY Stock Symbol:
OTCMKTS Market:
Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants PR Newswire REHOVOT, Israel , Feb. 25, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN) a regenerative and aesthetics medicine company, today announced that on ...